<DOC>
	<DOCNO>NCT02805439</DOCNO>
	<brief_summary>The purpose study assess efficacy safety S47445 versus placebo adjunctive treatment Major Depressive Disorder patient inadequate response antidepressant therapy .</brief_summary>
	<brief_title>Efficacy Safety S 47445 Versus Placebo Adjunctive Treatment Depressed Patients Not Fully Recovered From Depressive Symptoms With Current Antidepressant Treatment</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Outpatients Fulfilling DSM5 criterion Major Depressive Disorder confirm brief structured interview M.I.N.I . ( single recurrent episode , current episode ≤ 12 month , current depressive episode moderate severe intensity , without anxious distress , without melancholic feature , without mixed feature atypical feature , without seasonal pattern , without psychotic feature , without catatonic feature , without peripartum onset current episode ) Patients treated current depressive episode antidepressant treatment SSRI ( fluoxetine , citalopram , paroxetine , escitalopram sertraline ) give monotherapy recommend dose least 6 week 4 month stable dosage least 3 week HAMD total score ≥ 20 Clinical Global Impression Severity illness ( item 1 ) : 6 ≥ CGIS ≥ 4 Antidepressant Treatment Response Questionnaire ( ATQR ) &lt; 50 % current SSRI Absence abnormality likely interfere conduct study ( ECG , vital sign , laboratory test , medical history ) Depressive episode mild intensity accord DSM5 criterion All type depressive episode occur Major Depressive Disorder ( Persistent Depressive Disorder ( Dysthymia ) accord DSM5 criterion , include persistent depressive disorder intermittent persistent major depressive episode accord DSM5 , Premenstrual Dysphoric Disorder , Substance Induced Depressive Disorder , Depressive Disorder due another Medical Condition , Other Specified Unspecified Depressive Disorder , Bipolar Disorder I II , depress episode , Schizoaffective Disorder ( Depressive Bipolar type ) ) Depression onset within 12 month stroke Suicidal risk define score &gt; 3 item 3 HAMD scale investigator 's opinion Lactose intolerance Patients hereditary problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption Resistant depression current episode ( patient respond 1 previous antidepressant treatment SSRI take appropriate dose ) Current panic disorder Obsessive compulsive disorder Current post traumatic stress disorder , current acute stress disorder Current past psychotic disorder Any severe personality feature</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>